Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Acylated and unacylated ghrelin dosages----[3] 193, 201, 202 💬
2DTR Melatonin (NIH CC PDS)[1] Melatonin[1] Melatonin 💬 [2] MTNR1A,
MTNR1B 💬
[2] Circadian entrainment, Neuroactive ligand-receptor interaction 💬[1] 202 💬
3Enviro-light artificial light box----[1] 202 💬
4Hourly dosing of the nychtemeral secretion of melatonin[1] Melatonin[1] Melatonin 💬 [2] MTNR1A,
MTNR1B 💬
[2] Circadian entrainment, Neuroactive ligand-receptor interaction 💬[1] 202 💬
5Melatonin[1] Melatonin[1] Melatonin 💬 [2] MTNR1A,
MTNR1B 💬
[2] Circadian entrainment, Neuroactive ligand-receptor interaction 💬[18] 2, 6, 8, 13, 37, 46, 49, 72, 78, 86, 90, 96, 97, 145, 149, 159, 202, 265 💬
6Melatonin CR[1] Melatonin[1] Melatonin 💬 [2] MTNR1A,
MTNR1B 💬
[2] Circadian entrainment, Neuroactive ligand-receptor interaction 💬[1] 202 💬
7Phototherapy (Bright Light)----[1] 202 💬
8RM-493----[2] 193, 202 💬
9Setmelanotide[1] Setmelanotide[2] Setmelanotide ,
Setmelanotide acetate 💬
[1] MC4R 💬 [3] Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬[5] 134, 193, 202, 236, 265 💬
10Tasimelteon[1] Tasimelteon[1] Tasimelteon 💬 [2] MTNR1A,
MTNR1B 💬
[2] Circadian entrainment, Neuroactive ligand-receptor interaction 💬[1] 202 💬